Cover Kidney News
Volume/Issue:
Volume 14: Issue 6
Page:
28
Publication Date:
01 Jun 2022
Online Publication Date:
06 Jun 2022
Editorial Type:
Special Section

A Path to Training in Onconephrology

Omar Mamlouk Omar Mamlouk, MBBS, completed his nephrology fellowship at The University of Texas McGovern Medical School. During the fellowship, he had the opportunity to rotate at MD Anderson Cancer Center and developed an interest in onconephrology. He decided to pursue a 1-year onconephrology fellowship at MD Anderson Cancer Center to expand his knowledge of kidney diseases associated with cancer and cancer therapies, with special interest in immunotherapy-associated kidney toxicity. After graduation, he joined the Section of Nephrology at The University of Texas MD Anderson Center in Houston as faculty.

Search for other papers by Omar Mamlouk in
Current site
Google Scholar
PubMed Close
,
Marco Bonilla Marco Bonilla, MD, currently is a second-year nephrology fellow at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY, with an onconephrology and glomerular disease track. Since the beginning of his fellowship and under his mentor's guidance, he has been part of a dedicated onconephrology clinic and developed many collaborative partnerships with experts at a national and international level, thus creating a niche and tailoring his future academic career in this field. He will be joining an academic center in July 2022 with a vision to embark on onconephrology at that center.

Search for other papers by Marco Bonilla in
Current site
Google Scholar
PubMed Close
, and
Shveta Motwani Shveta Motwani, MD, MMSc, completed her nephrology fellowship at the Brigham and Women's and Massachusetts General Hospitals combined program in nephrology. Her interest in onconephrology began in her second year of internal medicine residency, and she organized her fellowship rank order list keeping this intention front and center. Starting in her second year of fellowship, she entered the continuity clinic in onconephrology and began formal training in research with the master's program in clinical and translational investigation at Harvard Medical School. After graduating from fellowship, she practiced as an onconephrologist at the Dana-Farber Cancer Institute and Brigham and Women's Hospital for 6 years, which concluded in March 2022. As of April 2022, she became the Director of Onconephrology at Lahey Hospital & Medical Center, Burlington, MA, to create an onconephrology program at that hospital.

Search for other papers by Shveta Motwani in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 14: Issue 6
Publication Date:
01 Jun 2022
Page:
28
Restricted access
Save